BDF
Balasa Dinverno & Foltz Portfolio holdings
AUM
$1.58B
1-Year Return
17.83%
This Quarter Return
+4.69%
1 Year Return
-17.83%
3 Year Return
+22.59%
5 Year Return
+46.43%
10 Year Return
–
AUM
$1.25B
AUM Growth
+$41.9M
(+3.5%)
Cap. Flow
-$10.1M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
63.99%
Holding
314
New
23
Increased
136
Reduced
120
Closed
9
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
$2.98M |
| 2 |
iShares International Equity Factor ETF
INTF
|
$2.63M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
$2.56M |
| 4 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
$2.38M |
| 5 |
Microsoft
MSFT
|
$1.63M |
Top Sells
| 1 |
Vanguard Small-Cap Growth ETF
VBK
|
$8.96M |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$5.62M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
$5.45M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
$2.61M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$2.04M |
Sector Composition
| 1 | Technology | 6.74% |
| 2 | Financials | 4% |
| 3 | Healthcare | 3.52% |
| 4 | Consumer Staples | 2.49% |
| 5 | Consumer Discretionary | 2.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
GrafTech
EAF
$256M
| $157K | 0.01% |
1,282
+90
| +8% | +$11K |
|
302
ING
ING
$71B
| $146K | 0.01% |
11,967
-8,939
| -43% | -$109K |
|
|
CS
303
DELISTED
Credit Suisse Group
CS
| $111K | 0.01% |
10,508
-4,187
| -28% | -$44.2K |
|
304
Banco Bilbao Vizcaya Argentaria
BBVA
$105B
| $71K | 0.01% |
+13,545
| New | +$71K |
|
305
Genworth Financial
GNW
$3.52B
| $36K | ﹤0.01% |
10,906
-6,998
| -39% | -$23.1K |
|
306
American Water Works
AWK
$28B
| – | – |
-2,165
| Closed | -$332K |
|
307
Equinix
EQIX
$75.7B
| – | – |
-351
| Closed | -$251K |
|
308
GE Aerospace
GE
$296B
| – | – |
-2,172
| Closed | -$117K |
|
309
W.W. Grainger
GWW
$47.5B
| – | – |
-598
| Closed | -$244K |
|
310
iShares Core MSCI Emerging Markets ETF
IEMG
$103B
| – | – |
-5,049
| Closed | -$313K |
|
311
Lumen
LUMN
$4.87B
| – | – |
-29,547
| Closed | -$288K |
|
312
McKesson
MCK
$85.5B
| – | – |
-1,168
| Closed | -$203K |
|
313
Rollins
ROL
$27.4B
| – | – |
-5,795
| Closed | -$226K |
|
314
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-984
| Closed | -$233K |
|